Open an Account
Open an Account

Week Ahead 30.11.20

Week Ahead 30.11.20

Week Ahead 30.11.20

in Weekly Market Brief

This week saw another strong risk on rally as a combination of positive factors came together. Firstly, news President Trump was prepared to start proceedings to transfer power to President elect Joe Biden relieved markets. Secondly, news that Janet Yellen would be appointed as Treasury Secretary encouraged risk as she is a vocal dove. Thirdly, positive vaccine news from across the world ranging from the West’s Pfizer to Russia’s Sputnik vaccine encouraged signs of coming global normality. This all sent risk on and allowed the Dow Jones index above 30,000 for the first ever time ahead of the US Thanksgiving holiday on Thursday.

Other key events from the past week

  • EUR: Key PMI data, November 23. Dropping eurozone PMI’s affirmed a second dip for the economy this week. The good news is the drop was helped by stronger manufacturing. Will the ECB now deliver more easing in December?
  • GBP: Fading Brexit optimism? November 25. EU Chief Negotiator Barnier told UK’s Chief Brexit negotiator Frost that if the most problematic points don’t change then the European negotiators have little reason to make the trip to London. Watch out for heavy GBP selling if negotiations stop altogether!
  • S&P500: Strong period for US stocks, November 20-Dec 06. The S&P500 started its strong seasonal pattern well. The S&P500 has gained value in eight of the last ten years from Nov 21 through to Dec 04.

Key events for the coming week

  • Oil: OPEC+ meets, November 30. OPEC+ meets this week to decide on output policy for next year. The recent rally in oil will need confirmation of the news that January’s planned output hike are delayed. If that news is not forthcoming then Brent’s 25% gain this month looks vulnerable to a correction lower.
  • AUD: Interest rate decision, December 01. This is the first central bank decision of December, but the RBA are not expected to change interest rates. However, investors will carefully watch for any change in forward guidance.
  • Vaccine Optimism: Global growth coming, December 04. Will this week register another strong rally in stocks on vaccine optimism?

Latest Posts

18/09/2020
FX Week Ahead 21.09.20
Weekly-Market-Brief-0906
09/06/2023
Tech rally exhaustion
25/03/2022
Bear market rally for stocks?
13/08/2021
USD gains on Jackson Hole taper announcement hopes

HYCM Lab is a financial analysis source that provides regular insights on how global news affects the markets including forex, commodities, stocks, indices, and cryptocurrencies*. Run by the HYCM team, it equips traders with everything needed to make informed trading decisions.

Legal Forms & Documents      |      Risk Warnings      |      Cookies Policy

Disclaimer: Any opinions made may be personal to the author and may not reflect the opinions of HYCM. All expressions of opinion are subject to change without notice. This material is considered a marketing communication and does not contain, and should not be construed as containing, investment advice or an investment recommendation or, an offer of or solicitation for any transactions in financial instruments. HYCM makes no representation and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied by an employee of HYCM, a third party or otherwise. Past performance is not an indication of possible future performance. Without the approval of HYCM, reproduction or redistribution of this information isn’t permitted.

Legal Information: HYCM is the trading name of HYCM Capital Markets (UK) Limited, HYCM (Europe) Ltd, HYCM Limited and HYCM Capital Markets (DIFC) Limited for which the HYCM Capital Markets group is holding company and its assets are a controlling equity interest in them.​

High-Risk Investment Warning: Contracts for Difference (‘CFDs’) are complex financial products that are traded on margin. Trading CFDs carries a high degree of risk. It is possible to lose all your capital. These products may not be suitable for everyone and you should ensure that you understand the risks involved. Seek independent expert advice if necessary and speculate only with funds that you can afford to lose. Please think carefully whether such trading suits you, taking into consideration all the relevant circumstances as well as your personal resources. We do not recommend clients posting their entire account balance to meet margin requirements. Clients can minimise their level of exposure by requesting a change in leverage limit. For more information please refer to HYCM’s Risk Disclosure.

*Cryptocurrencies are not available for trading under HYCM (Europe) Limited and HYCM Capital Markets (UK) Limited (retail clients only).

*Other fees may apply, such as withdrawal fees, dormant account fees, swaps, and spreads.

*Certain products & services mentioned herein may or may not be available to all clients depending on which HYCM Capital Markets Group entity their trading account(s) adheres to.

*Any opinions made in this material are personal to the author and do not reflect the opinions of HYCM. This material is considered a marketing communication and should not be construed as containing investment advice or an investment recommendation, or an offer of or solicitation for any transactions in financial instruments. Past performance is not a guarantee of or prediction of future performance. HYCM does not take into account your personal investment objectives or financial situation. HYCM makes no representation and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast, or other information supplied by an employee of HYCM, a third party or otherwise.

Copyright © 2023 HYCM

Legal Forms & Documents

Risk Warnings

Cookies Policy

Disclaimer: Any opinions made may be personal to the author and may not reflect the opinions of HYCM. All expressions of opinion are subject to change without notice. This material is considered a marketing communication and does not contain, and should not be construed as containing, investment advice or an investment recommendation or, an offer of or solicitation for any transactions in financial instruments. HYCM makes no representation and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied by an employee of HYCM, a third party or otherwise. Past performance is not an indication of possible future performance. Without the approval of HYCM, reproduction or redistribution of this information isn’t permitted.

Legal Information: HYCM is the trading name of Henyep Capital Markets (UK) Limited, HYCM (Europe) Ltd, HYCM Limited and Henyep Capital Markets (DIFC) Limited for which the Henyep Capital Markets group is holding company and its assets are a controlling equity interest in them.

* Cryptocurrencies are not available for trading under HYCM (Europe) Limited and Henyep Capital Markets (UK) Limited (retail clients only).

*Any opinions made in this material are personal to the author and do not reflect the opinions of HYCM. This material is considered a marketing communication and should not be construed as containing investment advice or an investment recommendation, or an offer of or solicitation for any transactions in financial instruments. Past performance is not a guarantee of or prediction of future performance. HYCM does not take into account your personal investment objectives or financial situation. HYCM makes no representation and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast, or other information supplied by an employee of HYCM, a third party or otherwise.

Copyright © 2023 HYCM